271 related articles for article (PubMed ID: 11301410)
1. Cyclopentenone prostaglandins: new insights on biological activities and cellular targets.
Straus DS; Glass CK
Med Res Rev; 2001 May; 21(3):185-210. PubMed ID: 11301410
[TBL] [Abstract][Full Text] [Related]
2. The cyclopentenone-type prostaglandin 15-deoxy-delta 12,14-prostaglandin J2 inhibits CD95 ligand gene expression in T lymphocytes: interference with promoter activation via peroxisome proliferator-activated receptor-gamma-independent mechanisms.
Cippitelli M; Fionda C; Di Bona D; Lupo A; Piccoli M; Frati L; Santoni A
J Immunol; 2003 May; 170(9):4578-92. PubMed ID: 12707336
[TBL] [Abstract][Full Text] [Related]
3. Structural requirements of cyclopentenone prostaglandins to induce endothelial cell apoptosis.
Vosseler CA; Erl W; Weber PC
Biochem Biophys Res Commun; 2003 Jul; 307(2):322-6. PubMed ID: 12859958
[TBL] [Abstract][Full Text] [Related]
4. Cyclopentenone prostaglandin receptors.
Negishi M; Katoh H
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():611-7. PubMed ID: 12432947
[TBL] [Abstract][Full Text] [Related]
5. Effects of cyclopentenone prostaglandins and related compounds on insulin-like growth factor-I and Waf1 gene expression.
Bui T; Straus DS
Biochim Biophys Acta; 1998 Apr; 1397(1):31-42. PubMed ID: 9545524
[TBL] [Abstract][Full Text] [Related]
6. Contribution of covalent protein modification to the antiinflammatory effects of cyclopentenone prostaglandins.
Pérez-Sala D; Cernuda-Morollón E; Pineda-Molina E; Cañada FJ
Ann N Y Acad Sci; 2002 Nov; 973():533-6. PubMed ID: 12485923
[TBL] [Abstract][Full Text] [Related]
7. The chemistry, biology and pharmacology of the cyclopentenone prostaglandins.
Burstein SH
Prostaglandins Other Lipid Mediat; 2020 Jun; 148():106408. PubMed ID: 31931079
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands as bifunctional regulators of cell proliferation.
Na HK; Surh YJ
Biochem Pharmacol; 2003 Oct; 66(8):1381-91. PubMed ID: 14555212
[TBL] [Abstract][Full Text] [Related]
9. Effects of 15-deoxy-delta 12, 14-prostaglandin J2 on the expression of p53 in MCF-7 cells.
Kim DH; Kim EH; Na HK; Surh YJ
Ann N Y Acad Sci; 2009 Aug; 1171():202-9. PubMed ID: 19723057
[TBL] [Abstract][Full Text] [Related]
10. Induction of apoptosis in estrogen receptor-negative breast cancer cells by natural and synthetic cyclopentenones: role of the IkappaB kinase/nuclear factor-kappaB pathway.
Ciucci A; Gianferretti P; Piva R; Guyot T; Snape TJ; Roberts SM; Santoro MG
Mol Pharmacol; 2006 Nov; 70(5):1812-21. PubMed ID: 16908599
[TBL] [Abstract][Full Text] [Related]
11. Cyclopentenone prostaglandins induce lymphocyte apoptosis by activating the mitochondrial apoptosis pathway independent of external death receptor signaling.
Nencioni A; Lauber K; Grünebach F; Van Parijs L; Denzlinger C; Wesselborg S; Brossart P
J Immunol; 2003 Nov; 171(10):5148-56. PubMed ID: 14607914
[TBL] [Abstract][Full Text] [Related]
12. A cyclopentenone prostaglandin activates mesangial MAP kinase independently of PPARgamma.
Wilmer WA; Dixon C; Lu L; Hilbelink T; Rovin BH
Biochem Biophys Res Commun; 2001 Feb; 281(1):57-62. PubMed ID: 11178960
[TBL] [Abstract][Full Text] [Related]
13. The biphasic effects of cyclopentenone prostaglandins, prostaglandin J(2) and 15-deoxy-Delta(12,14)-prostaglandin J(2) on proliferation and apoptosis in rat basophilic leukemia (RBL-2H3) cells.
Emi M; Maeyama K
Biochem Pharmacol; 2004 Apr; 67(7):1259-67. PubMed ID: 15013841
[TBL] [Abstract][Full Text] [Related]
14. Protein thiol modification by 15-deoxy-Delta12,14-prostaglandin J2 addition in mesangial cells: role in the inhibition of pro-inflammatory genes.
Sánchez-Gómez FJ; Cernuda-Morollón E; Stamatakis K; Pérez-Sala D
Mol Pharmacol; 2004 Nov; 66(5):1349-58. PubMed ID: 15317873
[TBL] [Abstract][Full Text] [Related]
15. Thioredoxin as a molecular target of cyclopentenone prostaglandins.
Shibata T; Yamada T; Ishii T; Kumazawa S; Nakamura H; Masutani H; Yodoi J; Uchida K
J Biol Chem; 2003 Jul; 278(28):26046-54. PubMed ID: 12709421
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of 15-deoxy-delta(12,14)-prostaglandin J2 and a peroxisome proliferator-activated receptor gamma agonist on macrophage activation.
Guyton K; Bond R; Reilly C; Gilkeson G; Halushka P; Cook J
J Leukoc Biol; 2001 Apr; 69(4):631-8. PubMed ID: 11310850
[TBL] [Abstract][Full Text] [Related]
17. Astrocytes synthesize primary and cyclopentenone prostaglandins that are negative regulators of their proliferation.
Chistyakov DV; Grabeklis S; Goriainov SV; Chistyakov VV; Sergeeva MG; Reiser G
Biochem Biophys Res Commun; 2018 Jun; 500(2):204-210. PubMed ID: 29634926
[TBL] [Abstract][Full Text] [Related]
18. Cyclopentenone prostaglandins with dienone structure promote cross-linking of the chemoresistance-inducing enzyme glutathione transferase P1-1.
Sánchez-Gómez FJ; Díez-Dacal B; Pajares MA; Llorca O; Pérez-Sala D
Mol Pharmacol; 2010 Oct; 78(4):723-33. PubMed ID: 20631055
[TBL] [Abstract][Full Text] [Related]
19. Cyclopentenone prostaglandins suppress activation of microglia: down-regulation of inducible nitric-oxide synthase by 15-deoxy-Delta12,14-prostaglandin J2.
Petrova TV; Akama KT; Van Eldik LJ
Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4668-73. PubMed ID: 10200320
[TBL] [Abstract][Full Text] [Related]
20. Cyclopentenone Prostaglandins and Structurally Related Oxidized Lipid Species Instigate and Share Distinct Pro- and Anti-inflammatory Pathways.
Muri J; Feng Q; Wolleb H; Shamshiev A; Ebner C; Tortola L; Broz P; Carreira EM; Kopf M
Cell Rep; 2020 Mar; 30(13):4399-4417.e7. PubMed ID: 32234476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
